Fibroblast growth factor gene expression in uterine leiomyomas;Ekspresja genu czynnika wzrostowego fibroblastów w mieśniakach macicy

Ginekologia Polska

Volumn 79, Issue 8, 2008, Pages 555-559

  Wolańska, Małgorzata ^a   Bańkowska Guszczyn, Emilia ^a   Jaworski, Stefan ^b  

^a Zak ad Biochemii Lekarskiej   (Poland)

^b Klinika Ginekologii   (Poland)

Author keywords

Fibroblast growth factor; Leiomyoma

Indexed keywords

EID: 54149115906     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ornitz D, Itoh N. Fibroblast growth factors. Genome Biol. 2001, 2, 1-12.
2. Wiedlocha A, Sorensen V. Signaling, internalization, and intracellular activity of fibroblast growth factor. Curr Top Microbiol Imunol. 2004, 286, 45-79.
3. Marquart F, Gillery P, Kalis B, [et al]. Cytokines and fibrosis. Eur J Dermatol. 1994, 4, 91-97.
4. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 1997, 11, 51-5.
5. Gallagher J. Heparan sulphate proteoglycans. The control of cell growth. In: Extracellular matrix 2. Ed. Comper W. Amsterdam: Harwood Academic Publishers, 1996, 230-245.
6. Wolańska M, Sobolewski K, Drozdzewicz M, [et al]. Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth. Mol Cell Biochem. 1998, 189, 145-152.
7. Wolańska M, Sobolewski K, Drozdzewicz M. Glikozoaminoglikany w mieśniakach macicy. Ginekol Pol. 1998, 69, 12-16.
8. Wolańska M, Bańkowski E. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of the tumour growth. Eur Cytokine Netw. 2004, 154, 359-363.
9. Wolańska M, Bańkowski E. Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth. Biochimie. 2006, 88, 141-146.
10. Wolańska M, Jaworski S. Czynnik wzrostu naskórka (EGF) w przebiegu wzrostu mieśniaków macicy. Ginekol Pol. 2005, 76, 643-647.
11. Wolańska M, Bańkowski E. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth. Eur J Obstet Gynecol Reprod Biol. 2007, 130, 238-244.
12. Unemori E, Werb Z. Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol. 1986, 103, 1021-1031.
13. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227, 680-685.
14. Hossain M, Fielding K, Trescher W, [et al]. Human FGF-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats. Eur J Neurosci. 1998, 10, 2490-2499.
15. Martineau Y, Le Bec C, Monbrun L, [et al]. Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol. 2004, 24, 7622-7635.
16. Bosman F, Stamenkovic I. Functional structure and composition of the extracellular matrix. J Pathol. 2003, 200, 423-428.
17. Ricciardelli C, Rodgers R. Extracellular matrix of ovarian tumors. Semin Reprod Med. 2006, 24, 270-282.
18. Schonherr E, Hausser H. Extracellular matrix and cytokines: a functional unit. Dev Immunol. 2000, 7, 89-101.
19. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991, 64, 867-869.
20. Debski R. Biologia mieśniaków. Hormony i cytokiny. Aspekty genetyczne. W: Mieśniaki macicy. Red. Markowska J. Warszawa: Wydawnictwo Lekarskie PZWL, 2000, 34-41.
21. Schuppan D, Ruhl M. Matrix in signal transduction and growth factor modulation. Braz J Med Biol Res. 1994, 27, 2125-2141.
22. Lee J, Juliano R. Mitogenic signal transduction by integrin and growth factor receptor-mediated pathways. Mol Cells. 2004, 17, 188-202.
23. Przybyłowska K, Błasiak J. Metaloproteinazy macierzowe i ich rola w procesie nowotworowym. Postepy Biochem. 2001, 47, 212-223.
24. Lemaitre V, D'Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today. 2006, 78, 1-10.
25. Wolańska M, Sobolewski K, Bańkowki E, [et al]. Matrix metalloproteinases of human leiomyoma in various stages of tumorgrowth. Gynecol Obstet Invest. 2004, 58, 14-18.
26. Wolańska M, Sobolewski K, Cechowska-Pasko M, [et al.]. The activities of some glycosaminoglycan-degrading enzymes in uterine leiomyomas. Eur J Obstet Gynecol Reprod Biol. 2003, 110, 73-78.
27. Petruzelka L. Diagnosis and treatment of tumor metastases. Vnitr Lek. 2001, 47, 555-560.
28. Jarzab B. Nowotwory. W: Patofizjologia kliniczna dla studentów medycyny. Red. Zahorska-Markiewicz B, Małecka-Tendera E. Wrocław: Volumed, 2001, 31-75.
29. Sozen I, Arici A. Interaction of cytokines, growth factors and the extracellular matrix in the cellular biology of uterine leiomyma. Fertil Steril. 2002, 78, 1-12.
30. Fayed Y, Tsibris J, Langenberg P, [et al.]. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platet-derived growth factors and insulin. Lab Invest. 1989, 60, 30-37.